ICD-10-CM › Z
ICD-10-CM codes starting with Z
1,866 codes, page 3 of 19. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| Z13.85 | Encounter for screening for nervous system disorders | Not billable |
| Z13.850 | Encounter for screening for traumatic brain injury | Valid |
| Z13.858 | Encounter for screening for other nervous system disorders | Valid |
| Z13.88 | Encounter for screening for disorder due to exposure to contaminants | Valid |
| Z13.89 | Encounter for screening for other disorder | Valid |
| Z13.9 | Encounter for screening, unspecified | Valid |
| Z14 | Genetic carrier | Not billable |
| Z14.0 | Hemophilia A carrier | Not billable |
| Z14.01 | Asymptomatic hemophilia A carrier | Valid |
| Z14.02 | Symptomatic hemophilia A carrier | Valid |
| Z14.1 | Cystic fibrosis carrier | Valid |
| Z14.8 | Genetic carrier of other disease | Valid |
| Z15 | Genetic susceptibility to disease | Not billable |
| Z15.0 | Genetic susceptibility to malignant neoplasm | Not billable |
| Z15.01 | Genetic susceptibility to malignant neoplasm of breast | Valid |
| Z15.02 | Genetic susceptibility to malignant neoplasm of ovary | Valid |
| Z15.03 | Genetic susceptibility to malignant neoplasm of prostate | Valid |
| Z15.04 | Genetic susceptibility to malignant neoplasm of endometrium | Valid |
| Z15.05 | Genetic susceptibility to malignant neoplasm of fallopian tube(s) | Valid |
| Z15.06 | Genetic susceptibility to malignant neoplasm of digestive system | Not billable |
| Z15.060 | Genetic susceptibility to colorectal cancer | Valid |
| Z15.068 | Genetic susceptibility to other malignant neoplasm of digestive system | Valid |
| Z15.07 | Genetic susceptibility to malignant neoplasm of urinary tract | Valid |
| Z15.09 | Genetic susceptibility to other malignant neoplasm | Valid |
| Z15.1 | Genetic susceptibility to epilepsy and neurodevelopmental disorders | Valid |
| Z15.2 | Genetic susceptibility to obesity | Valid |
| Z15.3 | Genetic susceptibility to kidney disease | Valid |
| Z15.8 | Genetic susceptibility to other disease | Not billable |
| Z15.81 | Genetic susceptibility to multiple endocrine neoplasia [MEN] | Valid |
| Z15.89 | Genetic susceptibility to other disease | Valid |
| Z16 | Resistance to antimicrobial drugs | Not billable |
| Z16.1 | Resistance to beta lactam antibiotics | Not billable |
| Z16.10 | Resistance to unspecified beta lactam antibiotics | Valid |
| Z16.11 | Resistance to penicillins | Valid |
| Z16.12 | Extended spectrum beta lactamase (ESBL) resistance | Valid |
| Z16.13 | Resistance to carbapenem | Valid |
| Z16.19 | Resistance to other specified beta lactam antibiotics | Valid |
| Z16.2 | Resistance to other antibiotics | Not billable |
| Z16.20 | Resistance to unspecified antibiotic | Valid |
| Z16.21 | Resistance to vancomycin | Valid |
| Z16.22 | Resistance to vancomycin related antibiotics | Valid |
| Z16.23 | Resistance to quinolones and fluoroquinolones | Valid |
| Z16.24 | Resistance to multiple antibiotics | Valid |
| Z16.29 | Resistance to other single specified antibiotic | Valid |
| Z16.3 | Resistance to other antimicrobial drugs | Not billable |
| Z16.30 | Resistance to unspecified antimicrobial drugs | Valid |
| Z16.31 | Resistance to antiparasitic drug(s) | Valid |
| Z16.32 | Resistance to antifungal drug(s) | Valid |
| Z16.33 | Resistance to antiviral drug(s) | Valid |
| Z16.34 | Resistance to antimycobacterial drug(s) | Not billable |
| Z16.341 | Resistance to single antimycobacterial drug | Valid |
| Z16.342 | Resistance to multiple antimycobacterial drugs | Valid |
| Z16.35 | Resistance to multiple antimicrobial drugs | Valid |
| Z16.39 | Resistance to other specified antimicrobial drug | Valid |
| Z17 | Estrogen, and other hormones and factors receptor status | Not billable |
| Z17.0 | Estrogen receptor positive status [ER+] | Valid |
| Z17.1 | Estrogen receptor negative status [ER-] | Valid |
| Z17.2 | Progesterone receptor status | Not billable |
| Z17.21 | Progesterone receptor positive status | Valid |
| Z17.22 | Progesterone receptor negative status | Valid |
| Z17.3 | Human epidermal growth factor 2 receptor | Not billable |
| Z17.31 | Human epidermal growth factor receptor 2 positive status | Valid |
| Z17.32 | Human epidermal growth factor receptor 2 negative status | Valid |
| Z17.4 | Combined receptor status | Not billable |
| Z17.41 | Hormone receptor positive | Not billable |
| Z17.410 | Hormone receptor positive with human epidermal growth factor receptor 2 positive status | Valid |
| Z17.411 | Hormone receptor positive with human epidermal growth factor receptor 2 negative status | Valid |
| Z17.42 | Hormone receptor negative | Not billable |
| Z17.420 | Hormone receptor negative with human epidermal growth factor receptor 2 positive status | Valid |
| Z17.421 | Hormone receptor negative with human epidermal growth factor receptor 2 negative status | Valid |
| Z18 | Retained foreign body fragments | Not billable |
| Z18.0 | Retained radioactive fragments | Not billable |
| Z18.01 | Retained depleted uranium fragments | Valid |
| Z18.09 | Other retained radioactive fragments | Valid |
| Z18.1 | Retained metal fragments | Not billable |
| Z18.10 | Retained metal fragments, unspecified | Valid |
| Z18.11 | Retained magnetic metal fragments | Valid |
| Z18.12 | Retained nonmagnetic metal fragments | Valid |
| Z18.2 | Retained plastic fragments | Valid |
| Z18.3 | Retained organic fragments | Not billable |
| Z18.31 | Retained animal quills or spines | Valid |
| Z18.32 | Retained tooth | Valid |
| Z18.33 | Retained wood fragments | Valid |
| Z18.39 | Other retained organic fragments | Valid |
| Z18.8 | Other specified retained foreign body | Not billable |
| Z18.81 | Retained glass fragments | Valid |
| Z18.83 | Retained stone or crystalline fragments | Valid |
| Z18.89 | Other specified retained foreign body fragments | Valid |
| Z18.9 | Retained foreign body fragments, unspecified material | Valid |
| Z19 | Hormone sensitivity malignancy status | Not billable |
| Z19.1 | Hormone sensitive malignancy status | Valid |
| Z19.2 | Hormone resistant malignancy status | Valid |
| Z20 | Contact with and (suspected) exposure to communicable diseases | Not billable |
| Z20.0 | Contact with and (suspected) exposure to intestinal infectious diseases | Not billable |
| Z20.01 | Contact with and (suspected) exposure to intestinal infectious diseases due to Escherichia coli (E. coli) | Valid |
| Z20.09 | Contact with and (suspected) exposure to other intestinal infectious diseases | Valid |
| Z20.1 | Contact with and (suspected) exposure to tuberculosis | Valid |
| Z20.2 | Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission | Valid |
| Z20.3 | Contact with and (suspected) exposure to rabies | Valid |
| Z20.4 | Contact with and (suspected) exposure to rubella | Valid |